Dr. Vivek Subbiah
Claim this profileMD Anderson Cancer Center
About Vivek Subbiah
Education:
- Obtained a medical degree from Sri Ramachandra Medical College and Research Institute, Chennai, India.
- Completed a combined residency in Internal Medicine and Pediatrics at Case Western Reserve University, MetroHealth, Cleveland, Ohio.
- Pursued fellowships in both adult and pediatric oncology at The University of Texas MD Anderson Cancer Center.
Experience:
- Served nearly 15 years at The University of Texas MD Anderson Cancer Center in various leadership roles, including Associate Professor and Executive Director of Medical Oncology Research.
- Principal investigator in over 100 phase I/II trials, significantly contributing to FDA and international approvals.
- Joined Sarah Cannon Research Institute in 2023 as Chief of Early-Phase Drug Development, leading the expansion of early-phase capabilities.
Area of expertise
Solid Tumors
Vivek Subbiah has run 21 trials for Solid Tumors. Some of their research focus areas include:
Cancer
Vivek Subbiah has run 15 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
M D Anderson Cancer Center
SCRI Oncology Partners
Clinical Trials Vivek Subbiah is currently running
GSK5764227
for Advanced Cancer
The goal of this study is to assess the safety, tolerability, clinical activity and pharmacokinetics of GSK5764227. The study will also see how the levels of GSK5764227 will change over time at different dose amounts when administered alone and in combination with other medicines like carboplatin, cisplatin, atezolizumab, pembrolizumab, durvalumab, bevacizumab, cetuximab.
Recruiting
1 award
Phase 1
2 criteria
EP0031
for Cancer
The aim of this study is to assess the safety, side effects and effectiveness of EP0031 in patients with advanced RET-altered malignancies (NSCLC)
Recruiting
1 award
Phase 1 & 2
More about Vivek Subbiah
Clinical Trial Related
4 years of experience running clinical trials · Led 32 trials as a Principal Investigator · 11 Active Clinical Trials
Treatments Vivek Subbiah has experience with
- Pembrolizumab
- Nivolumab
- Sapanisertib
- IO-108
- Cemiplimab
- Everolimus
Breakdown of trials Vivek Subbiah has run
Solid Tumors
Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vivek Subbiah specialize in?
Vivek Subbiah focuses on Solid Tumors and Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Vivek Subbiah currently recruiting for clinical trials?
Yes, Vivek Subbiah is currently recruiting for 11 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Vivek Subbiah has studied deeply?
Yes, Vivek Subbiah has studied treatments such as Pembrolizumab, Nivolumab, Sapanisertib.
What is the best way to schedule an appointment with Vivek Subbiah?
Apply for one of the trials that Vivek Subbiah is conducting.
What is the office address of Vivek Subbiah?
The office of Vivek Subbiah is located at: MD Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the MD Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.